How to be successful in remote work?
Preface: For many, the idea of working from home as a remote work can be exciting. But it does come with its own set of challenges. We share some simple …
Healthcare
Machine learning is the key to diagnose COVID‑19: a proof‑of‑concept study
Abstract The reverse transcription-polymerase chain reaction (RT-PCR) assay is the accepted standard for coronavirus disease 2019 (COVID-19) diagnosis. As any test, RT-PCR provides false negative results that can be rectified …
Machine learning is the key to diagnose COVID‑19: a proof‑of‑concept study Read More »
Covid 19 What happened to Europe?
Covid 19 What happened to Europe? More than a year has passed since the outbreak of the coronavirus(Covid 19) in Europe. The dream of Europe’s open borders has been to …
17,01,2021 Covid-19 vaccination in the world
With the start of the distribution of Corona vaccine in different countries of the world, many high-risk groups including medical staff and the elderly in different countries of the world as well as eight countries in the region including Saudi Arabia, UAE, Kuwait, Bahrain, Israel, Qatar, Oman and Turkey. They have received a dose of this vaccine.
AstraZeneca COVID-19 vaccine
AstraZeneca’s COVID-19 vaccine authorized for emergency supply in the UK
COVID-19 vaccine(AstraZeneca COVID-19 vaccine)in collaboration with the University of Oxford said it has developed a formula that protects citizens 100% against severe coronary heart disease, which leads to hospitalization. Pfizer and modern vaccines are equal.
oxford astrazeneca covid-19 vaccine results expected by christmas
Oxford-AstraZeneca COVID-19 vaccine results expected by Christmas University of Oxford scientists expect to report results from late-stage trials of the COVID-19 vaccine it is developing with AstraZeneca by late December. …
oxford astrazeneca covid-19 vaccine results expected by christmas Read More »
Pfizer and BioNTech Conclude Phase 3 Study of COVID-19 Vaccine
PFIZER AND BIONTECH CONCLUDE PHASE 3 STUDY OF COVID-19 VACCINE CANDIDATE, MEETING ALL PRIMARY EFFICACY ENDPOINTS Wednesday, November 18, 2020 – 06:59am Primary efficacy analysis demonstrates BNT162b2 to be 95% …
Pfizer and BioNTech Conclude Phase 3 Study of COVID-19 Vaccine Read More »
A Rapid, Accurate and Machine-Agnostic Segmentation and Quantification Method for CT-Based COVID-19 Diagnosis
Abstract COVID-19 has caused a global pandemic and become the most urgent threat to the entire world. Tremendous efforts and resources have been invested in developing diagnosis, prognosis and treatment …
Public Policy in a Pandemic: A Hazard-Control Perspective and a Case Study of the BCG Vaccine for COVID-19
Abstract The first cases of COVID-19 were reported in China in Dec 2019, quickly spreading to other parts of the world leading to a global pandemic. A number of potential …
Can the COVID-19 Epidemic Be Controlled on the Basis of Daily Test Reports?
Abstract This letter studies if and to which extent COVID-19 epidemics can be controlled by authorities taking decisions on public health measures on the basis of daily reports of swab …
Can the COVID-19 Epidemic Be Controlled on the Basis of Daily Test Reports? Read More »
